Literature DB >> 11004350

Procedure-related miscarriages and Down syndrome-affected births: implications for prenatal testing based on women's preferences.

M Kuppermann1, R F Nease, L A Learman, E Gates, B Blumberg, A E Washington.   

Abstract

OBJECTIVE: To determine how pregnant women of varying ages, races, ethnicities, and socioeconomic backgrounds value procedure-related miscarriage and Down-syndrome-affected birth.
METHODS: We studied cross-sectionally 534 sociodemographically diverse pregnant women who sought care at obstetric clinics and practices throughout the San Francisco Bay area. Preferences for procedure-related miscarriage and the birth of an infant affected by Down syndrome were assessed using the time trade-off and standard gamble metrics. Because current guidelines assume that procedure-related miscarriage and Down syndrome-affected birth are valued equally, we calculated the difference in preference scores for those two outcomes. We also collected detailed information on demographics, attitudes, and beliefs.
RESULTS: On average, procedure-related miscarriage was preferable to Down syndrome-affected birth, as evidenced by positive differences in preference scores for them (time trade-off difference: mean = 0.09, median = 0.06; standard gamble difference: mean = 0.11, median = 0.02; P <.001 for both, one-sample sign test). There was substantial subject-to-subject variation in preferences that correlated strongly with attitudes about miscarriage, Down syndrome, and diagnostic testing.
CONCLUSION: Pregnant women tend to find the prospect of a Down syndrome-affected birth more burdensome than a procedure-related miscarriage, calling into question the equal risk threshold for prenatal diagnosis. Individual preferences for those outcomes varied profoundly. Current guidelines do not appropriately consider individual preferences in lower-risk women, and the process for developing prenatal testing guidelines should be reconsidered to better reflect individual values.

Entities:  

Mesh:

Year:  2000        PMID: 11004350     DOI: 10.1016/s0029-7844(00)00969-8

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  23 in total

Review 1.  Disability and difference: balancing social and physical constructions.

Authors:  T Koch
Journal:  J Med Ethics       Date:  2001-12       Impact factor: 2.903

2.  Down's syndrome screening is unethical: views of today's research ethics committees.

Authors:  T M Reynolds
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

3.  Treating mild gestational diabetes mellitus: a cost-effectiveness analysis.

Authors:  Mika S Ohno; Teresa N Sparks; Yvonne W Cheng; Aaron B Caughey
Journal:  Am J Obstet Gynecol       Date:  2011-06-21       Impact factor: 8.661

4.  The cost-effectiveness of screening for gestational diabetes mellitus in primary and secondary care in the Republic of Ireland.

Authors:  Andriy Danyliv; Paddy Gillespie; Ciaran O'Neill; Marie Tierney; Angela O'Dea; Brian E McGuire; Liam G Glynn; Fidelma P Dunne
Journal:  Diabetologia       Date:  2015-12-15       Impact factor: 10.122

5.  Prenatal testing for Down syndrome: comparison of screening practices in the UK and USA.

Authors:  Dagmar Tapon
Journal:  J Genet Couns       Date:  2009-11-03       Impact factor: 2.537

6.  The assessment of combined first trimester screening in women of advanced maternal age in an Asian cohort.

Authors:  Sarah Weiling Li; Angela Natalie Barrett; Leena Gole; Wei Ching Tan; Arijit Biswas; Hak Koon Tan; Mahesh Choolani
Journal:  Singapore Med J       Date:  2015-01       Impact factor: 1.858

7.  Women's Preferences Regarding the Processes and Outcomes of Trial of Labor After Cesarean and Elective Repeat Cesarean Delivery.

Authors:  Anjali J Kaimal; William A Grobman; Allison S Bryant; Laura Norrell; Yamilee Bermingham; Anna Altshuler; Mari-Paule Thiet; Juan Gonzalez; Peter Bacchetti; Michelle Moghadassi; Miriam Kuppermann
Journal:  J Womens Health (Larchmt)       Date:  2019-05-21       Impact factor: 2.681

8.  The ethics of antenatal screening: lessons from Canute.

Authors:  Timothy M Reynolds
Journal:  Clin Biochem Rev       Date:  2009-11

9.  Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis.

Authors:  John F Mission; Mika S Ohno; Yvonne W Cheng; Aaron B Caughey
Journal:  Am J Obstet Gynecol       Date:  2012-06-29       Impact factor: 8.661

10.  Measuring the effects of unintended pregnancy on women's quality of life.

Authors:  Eleanor Bimla Schwarz; Rachel Smith; Jody Steinauer; Matthew F Reeves; Aaron B Caughey
Journal:  Contraception       Date:  2008-07-22       Impact factor: 3.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.